Integral Health Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-300,000
Closed -$17.9M 91
2021
Q3
$17.9M Buy
300,000
+75,000
+33% +$4.43M 5.14% 1
2021
Q2
$15.3M Buy
225,000
+15,000
+7% +$978K 4.22% 3
2021
Q1
$14.6M Buy
210,000
+10,000
+5% +$769K 4.16% 3
2020
Q4
$15.4M Buy
200,000
+50,000
+33% +$3.75M 4.57% 3
2020
Q3
$11.2M Sell
150,000
-25,000
-14% -$1.67M 3.43% 5
2020
Q2
$11M Buy
175,000
+65,000
+59% +$3.58M 3.3% 4
2020
Q1
$4.62M Buy
110,000
+40,000
+57% +$1.83M 2.04% 20
2019
Q4
$3.18M Buy
+70,000
New +$3.31M 1.24% 27

Other funds holding ARNA

Integral Health Asset Management's ARNA Position: Q4 2021 in Review

Integral Health Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 300,000 shares — an estimated $17.9M sold.

Integral Health Asset Management first reported a position in ARNA in Q4 2019 and held it in 8 quarters. The position peaked at $17.9M in Q3 2021. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • Integral Health Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Integral Health Asset Management sold 300,000 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $17.9M.
  • Integral Health Asset Management first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 8 quarters.
  • Integral Health Asset Management's Arena Pharmaceuticals Inc position peaked at $17.9M in Q3 2021.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Integral Health Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.